(Unaudited data)

  • CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2016
thousands of euros20152016Variation at current exchange ratesVariation at constant exchange rates
France361,765370,870+2.5%+2.5%
Europe (excluding France)167,714163,849-2.3%-0.3%
North America63,85864,916+1.7%+1.9%
Other countries14,46614,854+2.7%+3.7%
Group total607,803614,489+1.1%+1.7%

thousands of euros20152016Variation at current exchange ratesVariation at constant exchange rates
Non-proprietary Homeopathic Medicines310,555313,365+0.9%+0.9%
OTC Specialties296,954299,672+0.9%+2.1%
Other2941,452+393.9%+393.9%
Group total607,803614,489+1.1%+1.7%
  • QUARTERLY ACTIVITY IN 2016 (variation at current exchange rate)
thousands of euros1st quarter2nd quarter3rd quarter4th quarter
20152016Var.
16/15
20152016Var. 16/1520152016Var.
16/15
20152016Var.
16/15
France89,58490,494+1.0%76,86480,469+4.7%97,76798,840+1.1%97,550101,067+3.6%
Europe (excluding France)40,65743,685+7.4%29,94331,572+5.4%50,61441,273-18.5%46,50047,319+1.8%
North America17,19316,064-6.6%12,89414,113+9.5%16,05516,020-0.2%17,71618,719+5.7%
Other countries4,6223,846-16.8%3,8164,061+6.4%3,5943,280-8.7%2,4343,667+50.7%
Group total152,056154,089+1.3%123,517130,215+5.4%168,030159,413-5.1%164,200170,772+4.0%

thousands of euros1st quarter2nd quarter3rd quarter4th quarter
20152016Var.
16/15
20152016Var.
16/15
20152016Var.
16/15
20152016Var.
16/15
Non-proprietary Homeopathic Medicines79,19180,147+1.2%74,35476,001+2.2%73,67773,913+0.3%83,33383,304-0.0%
OTC Specialties72,88073,743+1.2%49,03053,719+9.6%94,32885,319-9.6%80,71686,891+7.7%
Other-15199133495+272.2%25181+624.0%151577+282.1%
Group total152,056154,089+1.3%123,517130,215+5.4%168,030159,413-5.1%164,200170,772+4.0%

HIGHLIGHTS OF THE FOURTH QUARTER

Sales revenue in the fourth quarter 2016 grew by 4% (+3.7% at constant rate). This growth is linked to the context of flu pathology at the end of the year.

Annual sales revenue amounted €614,489 thousand, in increase by 1.1% against 2015 (+1.7% at constant rate). Thus, the 2016 operating income will be slightly higher than in 2015.

On December 14, 2016, a project of new organization of the establishments in France has been presented to the Central Works Committee. The consultation with the social partners will continue until March 2017.

Our next update: March 15, 2017, after the close of the stock market, publication of 2016 results.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 – e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) – Bloomberg: BOI FP – Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com


Regulated information
News releases under ongoing reporting obligations:
– Information on annual revenues
– News releases under ongoing reporting obligations


Full and original press release in PDF:
https://www.actusnews.com/documents_communiques/ACTUS-0-47163-cp-boiron-260117.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it’s free

Print Friendly, PDF & Email

ACTIVITY IN 2016

ACTUALITÉS ÉCONOMIQUES ET FINANCIÈRES |